Horan Securities, Inc. Abb Vie Inc. Transaction History

Horan Securities, Inc.

$257 Million
Q3 2024

A detailed history of Horan Securities, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Horan Securities, Inc. holds 3,995 shares of ABBV stock, worth $680,348. This represents 0.31% of its overall portfolio holdings.

Number of Shares

3,995

Previous 3,854 3.66%

Holding current value

$680,348

Previous $661,000 19.21%

% of portfolio

0.31%

Previous 0.29%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $23,101 - $28,105	141 Added 3.66%	3,995 $788,000
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $1,238 - $1,446	8 Added 0.21%	3,854 $661,000
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $31,324 - $35,691	196 Added 5.37%	3,846 $700,000
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $1,926 - $2,169	14 Added 0.39%	3,650 $565,000
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $4,675 - $5,412	35 Added 0.97%	3,636 $541,000
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $4,637 - $5,771	35 Added 0.98%	3,601 $485,000
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $38,032 - $43,800	263 Added 7.96%	3,566 $568,000
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $4,979 - $5,971	36 Added 1.1%	3,303 $0
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $229,364 - $263,066	1,709 Added 109.69%	3,267 $438,000
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $43,900 - $55,812	-319 Reduced 17.0%	1,558 $238,000
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $20,852 - $25,872	158 Added 9.19%	1,877 $304,000
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $53,929 - $68,236	502 Added 41.25%	1,719 $233,000
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $61,968 - $69,036	589 Added 93.79%	1,217 $137,000
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $51,559 - $56,760	504 Added 406.45%	628 $68,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $3,783 - $5,107	47 Added 61.04%	124 $13,000
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $6,615 - $7,763	77 New	77 $7,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $0 - $0	0 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $0 - $0	0 New	0 $0
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $3,892 - $4,800	-50 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $3,492 - $4,461	50	50 $5,000

Others Institutions Holding ABBV

# of Institutions

3,870

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Securities, Inc. with notifications on news.

Account

Horan Securities, Inc. Abb Vie Inc. Transaction History